A carregar...
Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis
Tumor tissues are often absent or insufficient for testing epidermal growth factor receptor (EGFR) mutations to guide EGFR tyrosine kinase inhibitors (TKIs) treatment of patients with nonsmall cell lung cancer (NSCLC). We conducted this systematic review and meta-analysis to assess whether blood can...
Na minha lista:
Publicado no: | Medicine (Baltimore) |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Wolters Kluwer Health
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4616411/ https://ncbi.nlm.nih.gov/pubmed/26020382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000775 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|